Publications by Espen Melum

92 publications found

Publications 2024

1. Gregersen I, Kong XY, Kooijman S, Foyn H, Grannes H, Olsen MB, Lone AM, Yang K, Quiles-Jiménez A, Tran M, Øgaard J, Segers FM, Rashidi A, Sagen EL, Lauritzen KH, Pronk ACM, de Boer JF, Holven KB, Melum E, Aukrust P, Taskén K, Holm S, Rensen PCN, Dahl TB, Halvorsen B (2024)
   T cells with increased responsiveness cause obesity in mice without diet intervention
   iScience, 27 (4), 109471
   DOI 10.1016/j.isci.2024.109471, PubMed 38551005
2. Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS (2024)
   Author Correction: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
   Nature, 626 (8001), E19
   DOI 10.1038/s41586-024-07164-y, PubMed 38336833
3. Nikitina D, Lukosevicius R, Tilinde D, Muskieta T, Hov JR, Melum E, Klovins J, Org E, Kiudelis G, Kupcinskas J, Skieceviciene J (2024)
   Cell-Free Microbial DNA Analysis: Effects of Blood Plasma and Serum Quantity, Biobanking Protocols, and Isolation Kits
   Biopreserv Biobank (in press)
   DOI 10.1089/bio.2023.0048, PubMed 38416864
4. Oldereid TS, Jiang X, Øgaard J, Schrumpf E, Bjørnholt JV, Rasmussen H, Melum E (2024)
   Microbial exposure during early life regulates development of bile duct inflammation
   Scand J Gastroenterol, 59 (2), 192-201
   DOI 10.1080/00365521.2023.2278423, PubMed 37997753

Publications 2023

1. Andersen IM, Reims HM, Grzyb K, Fevang B, Melum E, Aukrust P, Wiencke K, Nordøy I, Line PD, Jørgensen SF (2023)
   Long-term survival after liver transplantation in patients with common variable immunodeficiency
   Liver Transpl, 29 (8), 894-899
   DOI 10.1097/LVT.0000000000000130, PubMed 36932715
2. Bergsmark T, Engesæter LK, Rasmussen A, Bennet W, Nordin A, Pall V, Line PD, Ericzon BG, Melum E (2023)
   Long-term survival after liver transplantation for alcohol-related liver disease in the Nordic countries
   Scand J Gastroenterol, 58 (8), 923-930
   DOI 10.1080/00365521.2023.2184193, PubMed 36872559
3. Braadland PR, Bergquist A, Kummen M, Bossen L, Engesæter LK, Reims HM, Björk I, Grzyb K, Abildgaard A, Småstuen MC, Folseraas T, Trøseid M, Ulvik A, Ueland PM, Melum E, Line PD, Høivik ML, Grønbæk H, Karlsen TH, Vesterhus M, Hov JR (2023)
   Clinical and biochemical impact of vitamin B6 deficiency in primary sclerosing cholangitis before and after liver transplantation
   J Hepatol, 79 (4), 955-966
   DOI 10.1016/j.jhep.2023.05.038, PubMed 37328069
4. Busek M, Aizenshtadt A, Koch T, Frank A, Delon L, Martinez MA, Golovin A, Dumas C, Stokowiec J, Gruenzner S, Melum E, Krauss S (2023)
   Pump-less, recirculating organ-on-a-chip (rOoC) platform
   Lab Chip, 23 (4), 591-608
   DOI 10.1039/d2lc00919f, PubMed 36655405
5. Harrison SP, Siller R, Tanaka Y, Chollet ME, de la Morena-Barrio ME, Xiang Y, Patterson B, Andersen E, Bravo-Pérez C, Kempf H, Åsrud KS, Lunov O, Dejneka A, Mowinckel MC, Stavik B, Sandset PM, Melum E, Baumgarten S, Bonanini F, Kurek D, Mathapati S, Almaas R, Sharma K, Wilson SR, Skottvoll FS et al. (2023)
   Scalable production of tissue-like vascularized liver organoids from human PSCs
   Exp Mol Med, 55 (9), 2005-2024
   DOI 10.1038/s12276-023-01074-1, PubMed 37653039
6. Jiang X, Otterdal K, Chung BK, Maucourant C, Rønneberg JD, Zimmer CL, Øgaard J, Boichuk Y, Holm S, Geanon D, Schneditz G, Bergquist A, Björkström NK, Melum E (2023)
   Cholangiocytes Modulate CD100 Expression in the Liver and Facilitate Pathogenic T-Helper 17 Cell Differentiation
   Gastroenterology, 166 (4), 667-679
   DOI 10.1053/j.gastro.2023.11.283, PubMed 37995866
7. Oldereid TS, Jiang X, Nordhus KS, Ponzetta A, Bjørnholt JV, Björkström NK, Melum E, Rasmussen H (2023)
   Role of bacteria and microbial metabolites in immune modulation during early life
   Scand J Immunol, 99 (2), e13336
   DOI 10.1111/sji.13336, PubMed 38441196
8. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2023)
   Author Correction: Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
   NPJ Vaccines, 8 (1), 4
   DOI 10.1038/s41541-023-00600-6, PubMed 36697432

Publications 2022

1. Brevini T, Maes M, Webb GJ, John BV, Fuchs CD, Buescher G, Wang L, Griffiths C, Brown ML, Scott WE, Pereyra-Gerber P, Gelson WTH, Brown S, Dillon S, Muraro D, Sharp J, Neary M, Box H, Tatham L, Stewart J, Curley P, Pertinez H, Forrest S, Mlcochova P, Varankar SS et al. (2022)
   FXR inhibition may protect from SARS-CoV-2 infection by reducing ACE2
   Nature, 615 (7950), 134-142
   DOI 10.1038/s41586-022-05594-0, PubMed 36470304
2. Chung BK, Øgaard J, Reims HM, Karlsen TH, Melum E (2022)
   Spatial transcriptomics identifies enriched gene expression and cell types in human liver fibrosis
   Hepatol Commun, 6 (9), 2538-2550
   DOI 10.1002/hep4.2001, PubMed 35726350
3. Tran TT, Vaage EB, Mehta A, Chopra A, Tietze L, Kolderup A, Anthi A, König M, Nygaard G, Lind A, Müller F, Nissen-Meyer LS, Magnus P, Trogstad L, Mjaaland S, Søraas A, Midtvedt K, Åsberg A, Barratt-Due A, Medhus AW, Høivik ML, Lundin K, Karlsen RF, Dahle R, Danielsson K et al. (2022)
   Titers of antibodies against ancestral SARS-CoV-2 correlate with levels of neutralizing antibodies to multiple variants
   NPJ Vaccines, 7 (1), 174
   DOI 10.1038/s41541-022-00586-7, PubMed 36585405
4. Tønnessen TC, Melleby AO, Hauge-Iversen IM, Espe EKS, Ahmed MS, Ueland T, Haavardsholm EA, Atkinson SM, Melum E, Attramadal H, Sjaastad I, Vinge LE (2022)
   Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice
   PLoS One, 17 (1), e0262821
   DOI 10.1371/journal.pone.0262821, PubMed 35077491
5. Valestrand L, Zheng F, Hansen SH, Øgaard J, Hov JR, Björkström NK, Karlsen TH, Jiang X, Melum E (2022)
   Bile from Patients with Primary Sclerosing Cholangitis Contains Mucosal-Associated Invariant T-Cell Antigens
   Am J Pathol, 192 (4), 629-641
   DOI 10.1016/j.ajpath.2021.12.008, PubMed 35063408
6. Yu J, Refsum E, Helsingen LM, Folseraas T, Ploner A, Wieszczy P, Barua I, Jodal HC, Melum E, Løberg M, Blom J, Bretthauer M, Adami HO, Kalager M, Ye W (2022)
   Risk of hepato-pancreato-biliary cancer is increased by primary sclerosing cholangitis in patients with inflammatory bowel disease: A population-based cohort study
   United European Gastroenterol J, 10 (2), 212-224
   DOI 10.1002/ueg2.12204, PubMed 35107865

Publications 2021

1. Hausken J, Haugaa H, Hagness M, Line PD, Melum E, Tønnessen TI (2021)
   Thoracic Epidural Analgesia for Postoperative Pain Management in Liver Transplantation: A 10-year Study on 685 Liver Transplant Recipients
   Transplant Direct, 7 (2), e648
   DOI 10.1097/TXD.0000000000001101, PubMed 33437863
2. Jiang X, Bergquist A, Löscher BS, Venkatesh G, Mold JE, Holm K, Laerdahl JK, Skånland SS, Maleki KT, Cornillet M, Taskén K, Franke A, Karlsen TH, Björkström NK, Melum E (2021)
   A heterozygous germline CD100 mutation in a family with primary sclerosing cholangitis
   Sci Transl Med, 13 (582)
   DOI 10.1126/scitranslmed.abb0036, PubMed 33627483
3. Jiang X, Melum E (2021)
   The Role of Natural Killer Cells in Nonalcoholic Steatohepatitis: An Ongoing Debate
   Cell Mol Gastroenterol Hepatol, 13 (1), 348-349
   DOI 10.1016/j.jcmgh.2021.10.006, PubMed 34740615
4. Lissing M, Nowak G, Adam R, Karam V, Boyd A, Gouya L, Meersseman W, Melum E, Ołdakowska-Jedynak U, Reiter FP, Colmenero J, Sanchez R, Herden U, Langendonk J, Ventura P, Isoniemi H, Boillot O, Braun F, Perrodin S, Mowlem E, Wahlin S, European Liver and Intestine Transplant Association (2021)
   Liver Transplantation for Acute Intermittent Porphyria
   Liver Transpl, 27 (4), 491-501
   DOI 10.1002/lt.25959, PubMed 33259654
5. Sampaziotis F, Muraro D, Tysoe OC, Sawiak S, Beach TE, Godfrey EM, Upponi SS, Brevini T, Wesley BT, Garcia-Bernardo J, Mahbubani K, Canu G, Gieseck R, Berntsen NL, Mulcahy VL, Crick K, Fear C, Robinson S, Swift L, Gambardella L, Bargehr J, Ortmann D, Brown SE, Osnato A, Murphy MP et al. (2021)
   Cholangiocyte organoids can repair bile ducts after transplantation in the human liver
   Science, 371 (6531), 839-846
   DOI 10.1126/science.aaz6964, PubMed 33602855
6. Zimmer CL, Filipovic I, Cornillet M, O'Rourke CJ, Berglin L, Jansson H, Sun D, Strauss O, Hertwig L, Johansson H, von Seth E, Sparrelid E, Dias J, Glaumann H, Melum E, Ellis EC, Sandberg JK, Andersen JB, Bergquist A, Björkström NK (2021)
   Mucosal-associated invariant T-cell tumor infiltration predicts long-term survival in cholangiocarcinoma
   Hepatology, 75 (5), 1154-1168
   DOI 10.1002/hep.32222, PubMed 34719787

Publications 2020

1. Louwe MC, Olsen MB, Kaasbøll OJ, Yang K, Fosshaug LE, Alfsnes K, Øgaard JDS, Rashidi A, Skulberg VM, Yang M, de Miranda Fonseca D, Sharma A, Aronsen JM, Schrumpf E, Ahmed MS, Dahl CP, Nyman TA, Ueland T, Melum E, Halvorsen BE, Bjørås M, Attramadal H, Sjaastad I, Aukrust P, Yndestad A (2020)
   Absence of NLRP3 Inflammasome in Hematopoietic Cells Reduces Adverse Remodeling After Experimental Myocardial Infarction
   JACC Basic Transl Sci, 5 (12), 1210-1224
   DOI 10.1016/j.jacbts.2020.09.013, PubMed 33426377
2. Valestrand L, Berntsen NL, Zheng F, Schrumpf E, Hansen SH, Karlsen TH, Blumberg RS, Hov JR, Jiang X, Melum E (2020)
   Lipid antigens in bile from patients with chronic liver diseases activate natural killer T cells
   Clin Exp Immunol, 203 (2), 304-314
   DOI 10.1111/cei.13541, PubMed 33089489

Publications 2019

1. Maroni L, Pinto C, Giordano DM, Saccomanno S, Banales JM, Spallacci D, Albertini MC, Orlando F, Provinciali M, Milkiewicz M, Melum E, Labiano I, Milkiewicz P, Rychlicki C, Trozzi L, Scarpelli M, Benedetti A, Svegliati Baroni G, Marzioni M (2019)
   Aging-Related Expression of Twinfilin-1 Regulates Cholangiocyte Biological Response to Injury
   Hepatology, 70 (3), 883-898
   DOI 10.1002/hep.30466, PubMed 30561764
2. Melum E, Jiang X, Baker KD, Macedo MF, Fritsch J, Dowds CM, Wang J, Pharo A, Kaser A, Tan C, Pereira CS, Kelly SL, Duan J, Karlsen TH, Exley MA, Schütze S, Zajonc DM, Merrill AH, Schuchman EH, Zeissig S, Blumberg RS (2019)
   Control of CD1d-restricted antigen presentation and inflammation by sphingomyelin
   Nat Immunol, 20 (12), 1644-1655
   DOI 10.1038/s41590-019-0504-0, PubMed 31636468
3. Tysoe OC, Justin AW, Brevini T, Chen SE, Mahbubani KT, Frank AK, Zedira H, Melum E, Saeb-Parsy K, Markaki AE, Vallier L, Sampaziotis F (2019)
   Isolation and propagation of primary human cholangiocyte organoids for the generation of bioengineered biliary tissue
   Nat Protoc, 14 (6), 1884-1925
   DOI 10.1038/s41596-019-0168-0, PubMed 31110298

Publications 2018

1. Berntsen NL, Fosby B, Tan C, Reims HM, Ogaard J, Jiang X, Schrumpf E, Valestrand L, Karlsen TH, Line PD, Blumberg RS, Melum E (2018)
   Natural killer T cells mediate inflammation in the bile ducts
   Mucosal Immunol, 11 (6), 1582-1590
   DOI 10.1038/s41385-018-0066-8, PubMed 30115993
2. Holmer M, Melum E, Isoniemi H, Ericzon BG, Castedal M, Nordin A, Aagaard Schultz N, Rasmussen A, Line PD, Stål P, Bennet W, Hagström H (2018)
   Nonalcoholic fatty liver disease is an increasing indication for liver transplantation in the Nordic countries
   Liver Int, 38 (11), 2082-2090
   DOI 10.1111/liv.13751, PubMed 29630771
3. Paquin-Proulx D, Greenspun BC, Pasquet L, Strunz B, Aleman S, Falconer K, Terabe M, Berzofsky JA, Sandberg JK, Melum E, Nixon DF, Björkström NK (2018)
   IL13Rα2 expression identifies tissue-resident IL-22-producing PLZF⁺ innate T cells in the human liver
   Eur J Immunol, 48 (8), 1329-1335
   DOI 10.1002/eji.201747334, PubMed 29677387
4. Pihlstrøm HK, Mjøen G, Mucha S, Franke A, Jardine A, Fellström B, Dahle DO, Holdaas H, Melum E (2018)
   Genetic markers associated with long-term cardiovascular outcome in kidney transplant recipients
   Am J Transplant, 19 (5), 1444-1451
   DOI 10.1111/ajt.15191, PubMed 30457209
5. Thorgersen EB, Melum E, Folseraas T, Larsen SG, Line PD (2018)
   Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for pseudomyxoma peritonei in a liver-transplanted patient: a case report
   World J Surg Oncol, 16 (1), 180
   DOI 10.1186/s12957-018-1482-7, PubMed 30185175

Publications 2017

1. Alberts R, de Vries EMG, Goode EC, Jiang X, Sampaziotis F, Rombouts K, Böttcher K, Folseraas T, Weismüller TJ, Mason AL, Wang W, Alexander G, Alvaro D, Bergquist A, Björkström NK, Beuers U, Björnsson E, Boberg KM, Bowlus CL, Bragazzi MC, Carbone M, Chazouillères O, Cheung A, Dalekos G, Eaton J et al. (2017)
   Genetic association analysis identifies variants associated with disease progression in primary sclerosing cholangitis
   Gut, 67 (8), 1517-1524
   DOI 10.1136/gutjnl-2016-313598, PubMed 28779025
2. Berntsen NL, Fosby B, Valestrand L, Tan C, Reims HM, Schrumpf E, Karlsen TH, Line PD, Melum E (2017)
   Establishment of a surgical bile duct injection technique giving direct access to the bile ducts for studies of the murine biliary tree
   Am J Physiol Gastrointest Liver Physiol, 314 (3), G349-G359
   DOI 10.1152/ajpgi.00124.2017, PubMed 29212771
3. Chellappa S, Hugenschmidt H, Hagness M, Subramani S, Melum E, Line PD, Labori KJ, Wiedswang G, Taskén K, Aandahl EM (2017)
   CD8+ T Cells That Coexpress RORγt and T-bet Are Functionally Impaired and Expand in Patients with Distal Bile Duct Cancer
   J Immunol, 198 (4), 1729-1739
   DOI 10.4049/jimmunol.1600061, PubMed 28053236
4. Henriksen EKK, Viken MK, Wittig M, Holm K, Folseraas T, Mucha S, Melum E, Hov JR, Lazaridis KN, Juran BD, Chazouillères O, Färkkilä M, Gotthardt DN, Invernizzi P, Carbone M, Hirschfield GM, Rushbrook SM, Goode E, UK-PSC Consortium, Ponsioen CY, Weersma RK, Eksteen B, Yimam KK, Gordon SC, Goldberg D et al. (2017)
   HLA haplotypes in primary sclerosing cholangitis patients of admixed and non-European ancestry
   HLA, 90 (4), 228-233
   DOI 10.1111/tan.13076, PubMed 28695657
5. Jiang X, Björkström NK, Melum E (2017)
   Intact CD100-CD72 Interaction Necessary for TCR-Induced T Cell Proliferation
   Front Immunol, 8, 765
   DOI 10.3389/fimmu.2017.00765, PubMed 28713384
6. Landskron J, Kraggerud SM, Wik E, Dørum A, Bjørnslett M, Melum E, Helland Ø, Bjørge L, Lothe RA, Salvesen HB, Taskén K (2017)
   C77G in PTPRC (CD45) is no risk allele for ovarian cancer, but associated with less aggressive disease
   PLoS One, 12 (7), e0182030
   DOI 10.1371/journal.pone.0182030, PubMed 28759630
7. Meijerink H, White RA, Løvlie A, de Blasio BF, Dalgard O, Amundsen EJ, Melum E, Kløvstad H (2017)
   Modelling the burden of hepatitis C infection among people who inject drugs in Norway, 1973-2030
   BMC Infect Dis, 17 (1), 541
   DOI 10.1186/s12879-017-2631-2, PubMed 28774261
8. Sampaziotis F, Justin AW, Tysoe OC, Sawiak S, Godfrey EM, Upponi SS, Gieseck RL, de Brito MC, Berntsen NL, Gómez-Vázquez MJ, Ortmann D, Yiangou L, Ross A, Bargehr J, Bertero A, Zonneveld MCF, Pedersen MT, Pawlowski M, Valestrand L, Madrigal P, Georgakopoulos N, Pirmadjid N, Skeldon GM, Casey J, Shu W et al. (2017)
   Reconstruction of the mouse extrahepatic biliary tree using primary human extrahepatic cholangiocyte organoids
   Nat Med, 23 (8), 954-963
   DOI 10.1038/nm.4360, PubMed 28671689
9. Schrumpf E, Jiang X, Zeissig S, Pollheimer MJ, Anmarkrud JA, Tan C, Exley MA, Karlsen TH, Blumberg RS, Melum E (2017)
   The role of natural killer T cells in a mouse model with spontaneous bile duct inflammation
   Physiol Rep, 5 (4)
   DOI 10.14814/phy2.13117, PubMed 28219981
10. Vesterhus M, Holm A, Hov JR, Nygård S, Schrumpf E, Melum E, Thorbjørnsen LW, Paulsen V, Lundin K, Dale I, Gilja OH, Zweers SJLB, Vatn M, Schaap FG, Jansen PLM, Ueland T, Røsjø H, Moum B, Ponsioen CY, Boberg KM, Färkkilä M, Karlsen TH, Lund-Johansen F (2017)
    Novel serum and bile protein markers predict primary sclerosing cholangitis disease severity and prognosis
    J Hepatol, 66 (6), 1214-1222
    DOI 10.1016/j.jhep.2017.01.019, PubMed 28161472

Publications 2016

1. Henriksen EK, Jørgensen KK, Kaveh F, Holm K, Hamm D, Olweus J, Melum E, Chung BK, Eide TJ, Lundin KE, Boberg KM, Karlsen TH, Hirschfield GM, Liaskou E (2016)
   Gut and liver T-cells of common clonal origin in primary sclerosing cholangitis-inflammatory bowel disease
   J Hepatol, 66 (1), 116-122
   DOI 10.1016/j.jhep.2016.09.002, PubMed 27647428
2. Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS (2016)
   Corrigendum: CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
   Nature, 536 (7616), 359
   DOI 10.1038/nature17421, PubMed 26982724
3. Ji SG, Juran BD, Mucha S, Folseraas T, Jostins L, Melum E, Kumasaka N, Atkinson EJ, Schlicht EM, Liu JZ, Shah T, Gutierrez-Achury J, Boberg KM, Bergquist A, Vermeire S, Eksteen B, Durie PR, Farkkila M, Müller T, Schramm C, Sterneck M, Weismüller TJ, Gotthardt DN, Ellinghaus D, Braun F et al. (2016)
   Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease
   Nat Genet, 49 (2), 269-273
   DOI 10.1038/ng.3745, PubMed 27992413
4. Maroni L, Agostinelli L, Saccomanno S, Pinto C, Giordano DM, Rychlicki C, De Minicis S, Trozzi L, Banales JM, Melum E, Karlsen TH, Benedetti A, Baroni GS, Marzioni M (2016)
   Nlrp3 Activation Induces Il-18 Synthesis and Affects the Epithelial Barrier Function in Reactive Cholangiocytes
   Am J Pathol, 187 (2), 366-376
   DOI 10.1016/j.ajpath.2016.10.010, PubMed 27912077
5. Pihlstrøm HK, Mjøen G, Mucha S, Haraldsen G, Franke A, Jardine A, Fellström B, Holdaas H, Melum E (2016)
   Single Nucleotide Polymorphisms and Long-Term Clinical Outcome in Renal Transplant Patients: A Validation Study
   Am J Transplant, 17 (2), 528-533
   DOI 10.1111/ajt.13995, PubMed 27483393
6. Schrumpf E, Kummen M, Valestrand L, Greiner TU, Holm K, Arulampalam V, Reims HM, Baines J, Bäckhed F, Karlsen TH, Blumberg RS, Hov JR, Melum E (2016)
   The gut microbiota contributes to a mouse model of spontaneous bile duct inflammation
   J Hepatol, 66 (2), 382-389
   DOI 10.1016/j.jhep.2016.09.020, PubMed 27720803
7. Vesterhus M, Melum E (2016)
   Prognostic biomarkers and surrogate end points in PSC
   Liver Int, 36 (12), 1748-1751
   DOI 10.1111/liv.13216, PubMed 27864874

Publications 2015

1. Andersen IM, Fosby B, Boberg KM, Clausen OP, Jebsen P, Melum E, Line PD, Foss A, Schrumpf E, Karlsen TH (2015)
   Indications and Outcomes in Liver Transplantation in Patients With Primary Sclerosing Cholangitis in Norway
   Transplant Direct, 1 (9), e39
   DOI 10.1097/TXD.0000000000000548, PubMed 27500239
2. Fosby B, Melum E, Bjøro K, Bennet W, Rasmussen A, Andersen IM, Castedal M, Olausson M, Wibeck C, Gotlieb M, Gjertsen H, Toivonen L, Foss S, Makisalo H, Nordin A, Sanengen T, Bergquist A, Larsson ME, Soderdahl G, Nowak G, Boberg KM, Isoniemi H, Keiding S, Foss A, Line PD et al. (2015)
   Liver transplantation in the Nordic countries - An intention to treat and post-transplant analysis from The Nordic Liver Transplant Registry 1982-2013
   Scand J Gastroenterol, 50 (6), 797-808
   DOI 10.3109/00365521.2015.1036359, PubMed 25959101
3. Liaskou E, Klemsdal Henriksen EK, Holm K, Kaveh F, Hamm D, Fear J, Viken MK, Hov JR, Melum E, Robins H, Olweus J, Karlsen TH, Hirschfield GM (2015)
   High-throughput T-cell receptor sequencing across chronic liver diseases reveals distinct disease-associated repertoires
   Hepatology, 63 (5), 1608-19
   DOI 10.1002/hep.28116, PubMed 26257205
4. Olin P, Hausken J, Foss A, Karlsen TH, Melum E, Haugaa H (2015)
   Continuous molecular adsorbent recirculating system treatment in 69 patients listed for liver transplantation
   Scand J Gastroenterol, 50 (9), 1127-34
   DOI 10.3109/00365521.2015.1027262, PubMed 25865318
5. Sampaziotis F, de Brito MC, Madrigal P, Bertero A, Saeb-Parsy K, Soares FAC, Schrumpf E, Melum E, Karlsen TH, Bradley JA, Gelson WT, Davies S, Baker A, Kaser A, Alexander GJ, Hannan NRF, Vallier L (2015)
   Cholangiocytes derived from human induced pluripotent stem cells for disease modeling and drug validation
   Nat Biotechnol, 33 (8), 845-852
   DOI 10.1038/nbt.3275, PubMed 26167629
6. Schrumpf E, Tan C, Karlsen TH, Sponheim J, Björkström NK, Sundnes O, Alfsnes K, Kaser A, Jefferson DM, Ueno Y, Eide TJ, Haraldsen G, Zeissig S, Exley MA, Blumberg RS, Melum E (2015)
   The biliary epithelium presents antigens to and activates natural killer T cells
   Hepatology, 62 (4), 1249-59
   DOI 10.1002/hep.27840, PubMed 25855031

Publications 2014

1. Eskesen AN, Bjøro K, Aandahl EM, Line PD, Melum E (2014)
   Low use of surveillance and early diagnosis of hepatocellular carcinoma in Norway--a population-based cohort study
   Cancer Epidemiol, 38 (6), 741-7
   DOI 10.1016/j.canep.2014.10.005, PubMed 25454262
2. Fickert P, Pollheimer MJ, Beuers U, Lackner C, Hirschfield G, Housset C, Keitel V, Schramm C, Marschall HU, Karlsen TH, Melum E, Kaser A, Eksteen B, Strazzabosco M, Manns M, Trauner M, International PSC Study Group (IPSCSG) (2014)
   Characterization of animal models for primary sclerosing cholangitis (PSC)
   J Hepatol, 60 (6), 1290-303
   DOI 10.1016/j.jhep.2014.02.006, PubMed 24560657
3. Fosby B, Næss S, Hov JR, Traherne J, Boberg KM, Trowsdale J, Foss A, Line PD, Franke A, Melum E, Scott H, Karlsen TH (2014)
   HLA variants related to primary sclerosing cholangitis influence rejection after liver transplantation
   World J Gastroenterol, 20 (14), 3986-4000
   DOI 10.3748/wjg.v20.i14.3986, PubMed 24744588
4. Henriksen EK, Melum E, Karlsen TH (2014)
   Update on primary sclerosing cholangitis genetics
   Curr Opin Gastroenterol, 30 (3), 310-9
   DOI 10.1097/MOG.0000000000000052, PubMed 24565892
5. Huang YH, Zhu C, Kondo Y, Anderson AC, Gandhi A, Russell A, Dougan SK, Petersen BS, Melum E, Pertel T, Clayton KL, Raab M, Chen Q, Beauchemin N, Yazaki PJ, Pyzik M, Ostrowski MA, Glickman JN, Rudd CE, Ploegh HL, Franke A, Petsko GA, Kuchroo VK, Blumberg RS (2014)
   CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
   Nature, 517 (7534), 386-90
   DOI 10.1038/nature13848, PubMed 25363763
6. Naess S, Björnsson E, Anmarkrud JA, Al Mamari S, Juran BD, Lazaridis KN, Chapman R, Bergquist A, Melum E, Marsh SG, Schrumpf E, Lie BA, Boberg KM, Karlsen TH, Hov JR (2014)
   Small duct primary sclerosing cholangitis without inflammatory bowel disease is genetically different from large duct disease
   Liver Int, 34 (10), 1488-95
   DOI 10.1111/liv.12492, PubMed 24517468
7. Næss S, Lie BA, Melum E, Olsson M, Hov JR, Croucher PJ, Hampe J, Thorsby E, Bergquist A, Traherne JA, Schrumpf E, Boberg KM, Schreiber S, Franke A, Karlsen TH (2014)
   Refinement of the MHC risk map in a scandinavian primary sclerosing cholangitis population
   PLoS One, 9 (12), e114486
   DOI 10.1371/journal.pone.0114486, PubMed 25521205
8. Zeissig S, Petersen BS, Tomczak M, Melum E, Huc-Claustre E, Dougan SK, Laerdahl JK, Stade B, Forster M, Schreiber S, Weir D, Leichtner AM, Franke A, Blumberg RS (2014)
   Early-onset Crohn's disease and autoimmunity associated with a variant in CTLA-4
   Gut, 64 (12), 1889-97
   DOI 10.1136/gutjnl-2014-308541, PubMed 25367873

Publications 2013

1. Ellinghaus D, Folseraas T, Holm K, Ellinghaus E, Melum E, Balschun T, Laerdahl JK, Shiryaev A, Gotthardt DN, Weismüller TJ, Schramm C, Wittig M, Bergquist A, Björnsson E, Marschall HU, Vatn M, Teufel A, Rust C, Gieger C, Wichmann HE, Runz H, Sterneck M, Rupp C, Braun F, Weersma RK et al. (2013)
   Genome-wide association analysis in primary sclerosing cholangitis and ulcerative colitis identifies risk loci at GPR35 and TCF4
   Hepatology, 58 (3), 1074-83
   DOI 10.1002/hep.25977, PubMed 22821403
2. Liu JZ, Hov JR, Folseraas T, Ellinghaus E, Rushbrook SM, Doncheva NT, Andreassen OA, Weersma RK, Weismüller TJ, Eksteen B, Invernizzi P, Hirschfield GM, Gotthardt DN, Pares A, Ellinghaus D, Shah T, Juran BD, Milkiewicz P, Rust C, Schramm C, Müller T, Srivastava B, Dalekos G, Nöthen MM, Herms S et al. (2013)
   Dense genotyping of immune-related disease regions identifies nine new risk loci for primary sclerosing cholangitis
   Nat Genet, 45 (6), 670-5
   DOI 10.1038/ng.2616, PubMed 23603763
3. Zeissig S, Olszak T, Melum E, Blumberg RS (2013)
   Analyzing antigen recognition by Natural Killer T cells
   Methods Mol Biol, 960, 557-572
   DOI 10.1007/978-1-62703-218-6_41, PubMed 23329514

Publications 2012

1. Eskesen AN, Melum E, Moghaddam A, Bjøro K, Verbaan H, Ring-Larsen H, Dalgard O (2012)
   Genetic variants at the ITPA locus protect against ribavirin-induced hemolytic anemia and dose reduction in an HCV G2/G3 cohort
   Eur J Gastroenterol Hepatol, 24 (8), 890-6
   DOI 10.1097/MEG.0b013e3283546efd, PubMed 22584257
2. Folseraas T, Melum E, Rausch P, Juran BD, Ellinghaus E, Shiryaev A, Laerdahl JK, Ellinghaus D, Schramm C, Weismüller TJ, Gotthardt DN, Hov JR, Clausen OP, Weersma RK, Janse M, Boberg KM, Björnsson E, Marschall HU, Cleynen I, Rosenstiel P, Holm K, Teufel A, Rust C, Gieger C, Wichmann HE et al. (2012)
   Extended analysis of a genome-wide association study in primary sclerosing cholangitis detects multiple novel risk loci
   J Hepatol, 57 (2), 366-75
   DOI 10.1016/j.jhep.2012.03.031, PubMed 22521342
3. Forster M, Forster P, Elsharawy A, Hemmrich G, Kreck B, Wittig M, Thomsen I, Stade B, Barann M, Ellinghaus D, Petersen BS, May S, Melum E, Schilhabel MB, Keller A, Schreiber S, Rosenstiel P, Franke A (2012)
   From next-generation sequencing alignments to accurate comparison and validation of single-nucleotide variants: the pibase software
   Nucleic Acids Res, 41 (1), e16
   DOI 10.1093/nar/gks836, PubMed 22965131
4. Fosby B, Karlsen TH, Melum E (2012)
   Recurrence and rejection in liver transplantation for primary sclerosing cholangitis
   World J Gastroenterol, 18 (1), 1-15
   DOI 10.3748/wjg.v18.i1.1, PubMed 22228965
5. Srivastava B, Mells GF, Cordell HJ, Muriithi A, Brown M, Ellinghaus E, Franke A, UK-PSC Consortium, Karlsen TH, Sandford RN, Alexander GJ, Chapman RW, Rushbrook SM, Melum E (2012)
   Fine mapping and replication of genetic risk loci in primary sclerosing cholangitis
   Scand J Gastroenterol, 47 (7), 820-6
   DOI 10.3109/00365521.2012.682090, PubMed 22554193

Publications 2011

1. Folseraas T, Melum E, Franke A, Karlsen TH (2011)
   Genetics in primary sclerosing cholangitis
   Best Pract Res Clin Gastroenterol, 25 (6), 713-26
   DOI 10.1016/j.bpg.2011.09.010, PubMed 22117637
2. Janse M, Lamberts LE, Franke L, Raychaudhuri S, Ellinghaus E, Muri Boberg K, Melum E, Folseraas T, Schrumpf E, Bergquist A, Björnsson E, Fu J, Jan Westra H, Groen HJ, Fehrmann RS, Smolonska J, van den Berg LH, Ophoff RA, Porte RJ, Weismüller TJ, Wedemeyer J, Schramm C, Sterneck M, Günther R, Braun F et al. (2011)
   Three ulcerative colitis susceptibility loci are associated with primary sclerosing cholangitis and indicate a role for IL2, REL, and CARD9
   Hepatology, 53 (6), 1977-85
   DOI 10.1002/hep.24307, PubMed 21425313
3. Moghaddam A, Melum E, Reinton N, Ring-Larsen H, Verbaan H, Bjøro K, Dalgard O (2011)
   IL28B genetic variation and treatment response in patients with hepatitis C virus genotype 3 infection
   Hepatology, 53 (3), 746-54
   DOI 10.1002/hep.24154, PubMed 21374656

Publications 2010

1. Evang JA, Borota OC, Melum E, Holm R, Ramm-Pettersen J, Bollerslev J, Berg JP (2010)
   HDAC2 expression and variable number of repeats in exon 1 of the HDAC2 gene in corticotroph adenomas
   Clin Endocrinol (Oxf), 73 (2), 229-35
   DOI 10.1111/j.1365-2265.2010.03805.x, PubMed 20346000
2. Holm K, Melum E, Franke A, Karlsen TH (2010)
   SNPexp - A web tool for calculating and visualizing correlation between HapMap genotypes and gene expression levels
   BMC Bioinformatics, 11, 600
   DOI 10.1186/1471-2105-11-600, PubMed 21167019
3. Hov JR, Keitel V, Laerdahl JK, Spomer L, Ellinghaus E, ElSharawy A, Melum E, Boberg KM, Manke T, Balschun T, Schramm C, Bergquist A, Weismüller T, Gotthardt D, Rust C, Henckaerts L, Onnie CM, Weersma RK, Sterneck M, Teufel A, Runz H, Stiehl A, Ponsioen CY, Wijmenga C, Vatn MH et al. (2010)
   Mutational characterization of the bile acid receptor TGR5 in primary sclerosing cholangitis
   PLoS One, 5 (8), e12403
   DOI 10.1371/journal.pone.0012403, PubMed 20811628
4. Karlsen TH, Melum E, Franke A (2010)
   The utility of genome-wide association studies in hepatology
   Hepatology, 51 (5), 1833-42
   DOI 10.1002/hep.23564, PubMed 20232293
5. Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF (2010)
   Association to the Glypican-5 gene in multiple sclerosis
   J Neuroimmunol, 226 (1-2), 194-7
   DOI 10.1016/j.jneuroim.2010.07.003, PubMed 20692050
6. Melum E, Franke A, Schramm C, Weismüller TJ, Gotthardt DN, Offner FA, Juran BD, Laerdahl JK, Labi V, Björnsson E, Weersma RK, Henckaerts L, Teufel A, Rust C, Ellinghaus E, Balschun T, Boberg KM, Ellinghaus D, Bergquist A, Sauer P, Ryu E, Hov JR, Wedemeyer J, Lindkvist B, Wittig M et al. (2010)
   Genome-wide association analysis in primary sclerosing cholangitis identifies two non-HLA susceptibility loci
   Nat Genet, 43 (1), 17-9
   DOI 10.1038/ng.728, PubMed 21151127
7. Melum E, May S, Schilhabel MB, Thomsen I, Karlsen TH, Rosenstiel P, Schreiber S, Franke A (2010)
   SNP discovery performance of two second-generation sequencing platforms in the NOD2 gene region
   Hum Mutat, 31 (7), 875-85
   DOI 10.1002/humu.21276, PubMed 20506538

Publications 2009

1. Karlsen TH, Franke A, Melum E, Kaser A, Hov JR, Balschun T, Lie BA, Bergquist A, Schramm C, Weismüller TJ, Gotthardt D, Rust C, Philipp EE, Fritz T, Henckaerts L, Weersma RK, Stokkers P, Ponsioen CY, Wijmenga C, Sterneck M, Nothnagel M, Hampe J, Teufel A, Runz H, Rosenstiel P et al. (2009)
   Genome-wide association analysis in primary sclerosing cholangitis
   Gastroenterology, 138 (3), 1102-11
   DOI 10.1053/j.gastro.2009.11.046, PubMed 19944697
2. Melum E, Franke A, Karlsen TH (2009)
   Genome-wide association studies--a summary for the clinical gastroenterologist
   World J Gastroenterol, 15 (43), 5377-96
   DOI 10.3748/wjg.15.5377, PubMed 19916168

Publications 2008

1. Melum E, Buch S, Schafmayer C, Kalthoff H, Tepel J, Schreiber S, Karlsen TH, Hampe J (2008)
   Investigation of cholangiocarcinoma associated NKG2D polymorphisms in colorectal carcinoma
   Int J Cancer, 123 (1), 241-2
   DOI 10.1002/ijc.23517, PubMed 18398827
2. Melum E, Karlsen TH, Bergquist A, Schrumpf E, Boberg KM (2008)
   An interleukin-6 (IL-6) receptor polymorphism affecting serum levels of IL-6 does not increase the risk of cholangiocarcinoma in primary sclerosing cholangitis
   Am J Gastroenterol, 103 (4), 1045; author reply 1045-6
   DOI 10.1111/j.1572-0241.2007.01772_5.x, PubMed 18397431
3. Melum E, Karlsen TH, Schrumpf E, Bergquist A, Thorsby E, Boberg KM, Lie BA (2008)
   Cholangiocarcinoma in primary sclerosing cholangitis is associated with NKG2D polymorphisms
   Hepatology, 47 (1), 90-6
   DOI 10.1002/hep.21964, PubMed 18023027

Publications 2007

1. Lindner E, Nordang GB, Melum E, Flatø B, Selvaag AM, Thorsby E, Kvien TK, Førre OT, Lie BA (2007)
   Lack of association between the chemokine receptor 5 polymorphism CCR5delta32 in rheumatoid arthritis and juvenile idiopathic arthritis
   BMC Med Genet, 8, 33
   DOI 10.1186/1471-2350-8-33, PubMed 17565662
2. Melum E, Friman S, Bjøro K, Rasmussen A, Isoniemi H, Gjertsen H, Bäckman L, Oksanen A, Olausson M, Duraj FF, Ericzon BG (2007)
   Hepatitis C impairs survival following liver transplantation irrespective of concomitant hepatocellular carcinoma
   J Hepatol, 47 (6), 777-83
   DOI 10.1016/j.jhep.2007.06.013, PubMed 17714825

Publications 2006

1. Melum E, Karlsen TH, Broomé U, Thorsby E, Schrumpf E, Boberg KM, Lie BA (2006)
   The 32-base pair deletion of the chemokine receptor 5 gene (CCR5-Delta32) is not associated with primary sclerosing cholangitis in 363 Scandinavian patients
   Tissue Antigens, 68 (1), 78-81
   DOI 10.1111/j.1399-0039.2006.00604.x, PubMed 16774544
2. Melum E, Schrumpf E, Bjøro K (2006)
   Liver TX for hepatitis C cirrhosis in a low prevalence population: risk factors and status at evaluation
   Scand J Gastroenterol, 41 (5), 592-6
   DOI 10.1080/00365520500347113, PubMed 16638703